Compound ID | 2877
Class: Beta-lactam + beta-lactamase inhibitor
| Spectrum of activity: | Gram-negative |
| Details of activity: | Active against carbapenemase-producing Enterobacteriaceae; inhibits class A, C, and some D beta-lactamases |
| Combined with other compounds: | Yes |
| Description: | Synthetic compound |
| Institute where first reported: | QiLu Pharmaceutical |
| Year first mentioned: | 2023 |
| Highest developmental phase: | Phase 2 (NCT05060419) |
| Development status: | Active as of 2024 |
| Chemical structure(s): | |||||||||||
|
|